Vera Therapeutics Inc (VERA)
43.45
-0.05
(-0.11%)
USD |
NASDAQ |
May 03, 16:00
43.45
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics 1 Year Total Returns (Daily): 544.4% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | 544.4% |
May 01, 2024 | 508.9% |
April 30, 2024 | 494.1% |
April 29, 2024 | 522.3% |
April 26, 2024 | 525.4% |
April 25, 2024 | 511.2% |
April 24, 2024 | 524.2% |
April 23, 2024 | 505.2% |
April 22, 2024 | 499.2% |
April 19, 2024 | 482.8% |
April 18, 2024 | 516.9% |
April 17, 2024 | 527.1% |
April 16, 2024 | 578.9% |
April 15, 2024 | 642.1% |
April 12, 2024 | 670.0% |
April 11, 2024 | 695.1% |
April 10, 2024 | 565.9% |
April 09, 2024 | 520.5% |
April 08, 2024 | 532.2% |
April 05, 2024 | 470.2% |
April 04, 2024 | 424.7% |
April 03, 2024 | 423.8% |
April 02, 2024 | 426.4% |
April 01, 2024 | 445.7% |
March 28, 2024 | 493.9% |
Date | Value |
---|---|
March 27, 2024 | 500.4% |
March 26, 2024 | 453.7% |
March 25, 2024 | 448.3% |
March 22, 2024 | 454.8% |
March 21, 2024 | 477.0% |
March 20, 2024 | 506.0% |
March 19, 2024 | 509.0% |
March 18, 2024 | 481.6% |
March 15, 2024 | 506.6% |
March 14, 2024 | 507.5% |
March 13, 2024 | 514.5% |
March 12, 2024 | 499.6% |
March 11, 2024 | 485.9% |
March 08, 2024 | 447.6% |
March 07, 2024 | 422.9% |
March 06, 2024 | 448.7% |
March 05, 2024 | 499.6% |
March 04, 2024 | 518.1% |
March 01, 2024 | 564.1% |
February 29, 2024 | 533.6% |
February 28, 2024 | 518.3% |
February 27, 2024 | 546.2% |
February 26, 2024 | 519.7% |
February 23, 2024 | 526.8% |
February 22, 2024 | 525.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-76.89%
Minimum
Jan 06 2023
695.1%
Maximum
Apr 11 2024
52.16%
Average
-13.12%
Median
1 Year Total Returns (Daily) Benchmarks
Vertex Pharmaceuticals Inc | 15.64% |
Alpine Immune Sciences Inc | 812.3% |
Fate Therapeutics Inc | -30.91% |
Checkpoint Therapeutics Inc | -51.32% |
Mersana Therapeutics Inc | -23.06% |